産前オピオイド暴露に関する系統的研究:神経発達への影響のレビュー
1Neuroscience and Behavioral Biology Department, Emory University, Atlanta, GA; and.
Journal of developmental and behavioral pediatrics : JDBP
|August 27, 2025
まとめ
産前オピオイドへの曝露は神経発達,特に神経感覚と社会感情の領域にリスクをもたらします. 母親のオピオイド使用は 子どもの神経発達を監視する必要があります
科学分野:
- 神経科学
- 発達心理学
- 公衆衛生
背景:
- 産前オピオイドへの曝露は,子供の発達に長期的な影響を及ぼす可能性があるという懸念が高まっています.
- 早期の介入と支援には 特定の神経発達への影響を理解することが不可欠です
研究 の 目的:
- 産前オピオイド暴露に関連した神経発達の悪影響を体系的に検討し評価する.
- 様々な神経行動と神経イメージングの分野での発見を統合する.
主な方法:
- 体系的なレビューとメタ分析 (PRISMA) のガイドラインに従って体系的なレビューを行う.
- 推薦,評価,開発,評価の格付け (GRADE) システムを使用して評価した86件の研究が含まれています.
- 結果は6つの神経行動領域と1つの神経イメージング領域に分類されます.
主要な成果:
- 神経感覚領域では,産前オピオイド被曝の子どもで障害のリスクが最も高かった (76. 9%).
- 社会的感情的な領域は,ネガティブな影響の最大の効果サイズを示した (ヘッジのg = -1.14).
- 神経画像の研究は限られ,異質で,決定的な結論を阻害しました.
結論:
- 妊娠中の母親のオピオイド使用は発達モニタリングのリスク指標です.
- 薬物の同時使用や社会的逆境などの混同要因のために直接的なテロゲニック効果を確かめるのは困難です.
さらに関連する動画
15:27Construction of Vapor Chambers Used to Expose Mice to Alcohol During the Equivalent of all Three Trimesters of Human Development
Published on: July 13, 2014
14.8K
05:13Preclinical Model of Prenatal Delta-9-Tetrahydrocannabinol Exposure to Assess Its Impact on Neurodevelopmental Outcomes
Published on: February 28, 2025
329
関連する概念動画
Teratogenicity
4.2K
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
4.2K
Drug Abuse and Addiction: Pharmacological Phenomena
1.6K
Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not...
1.6K
Opioid Receptors: Overview
7.2K
Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2,...
7.2K
Analgesia and Pain Management
3.3K
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
3.3K
Opioid Analgesics: Morphine and Other Natural Cogeners
1.7K
Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
1.7K
